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Available online 16 March 2016Background: Transverse aortic constriction (TAC) operation is used as an experimental model of left ventricular
(LV) hypertrophy and LV failure in mice. The severity of LV remodeling or failure may depend on the degree of
TAC, but is variable among operated animals. Therefore,we tried to identify the optimal diameter of TAC to create
this model with ease and high reproducibility.
Methods and results: To produce TAC in C57BL/6J mice (7–9 weeks, body weight 19–26 g, n = 109), a 7–0 nylon
suture ligature was tightly tied around the transverse aorta against needles with 3 different diameters (mm);
0.40, 0.385 and 0.375. LVwall thickness, end-diastolic dimension, fractional shorteningweremeasured by echocar-
diography. At 4 weeks after TAC, no mouse with the 0.400 mm gauge progressed in LV failure. The 0.385 mm pin
gauge mouse kept a more survival rate compared with the 0.375 mm (59% vs 48%), representing same efﬁcient
in LV failure.With the 0.385mmpin gauge, hearts of mice remained LV hypertrophy at 1 week after TAC, followed
by LV failure at 4 weeks.
Conclusion: TACwith the diameter of 0.385mmcan effectively induce the transition from LV hypertrophy to failure
in mice with relatively preserved survival.







To investigate the effect of drug therapy and the molecular mecha-
nism for heart failure (HF), researchers have used three main models of
HF inmice;myocardial infarction (MI) by coronary artery ligation, chron-
ic pressure overload model by transverse aortic constriction (TAC), and
chronic volume overload by aortocaval ﬁstula [1]. TAC operation is
often used as an experimental model of left ventricular (LV) hypertrophy
andHF inmice. In spite of very commonmodel, TACmodel has a diversity
of the severity of LV remodeling or HF, which has been shown to depend
on strain [2], sex [3] and standardizing needle size used for TAC operation
[4]. Strain and sex of mice can be determined by study design. However,
only the needle sizes need to be adjusted to create an appropriate model
for the purpose of study.
In recent studies, needle sizes from 24 to 28-gauge, frequently
27-gauge (0.40 mm outside diameter (OD)), have been selected in
TAC operation [5–7]. In the study of HF, we need mice model with se-
vere HF and obvious LV remodeling by TAC keeping high survival rate.
However, we actually noticed that some mice remained hypertrophyvascular Medicine, Hokkaido
7, Kita-ku, Sapporo 060-8638,
gawa).
land Ltd. This is an open access articlwithout themanifestations of HF in survivingmice, others died quickly.
The purpose of this study waswhich size of gauges was suitable for TAC
operation from the point of view of survival and severity of HF.
Now pin gauges for industrial use are commercially available, which
can vary its size used for TAC operation in 0.005mm increments. To de-
termine which size of gauges is most suitable for TAC operation, we
studied survival and severity of HF after TAC by using three sizes of
gauges; medical needle with a 0.400 mm OD, pin gauges for industrial
use with a 0.385 mm OD and a 0.375 mm OD.
2. Methods
All experimental procedures and animal care were approved by our
institutional animal research committee and conformed to the Animal
Care Guideline for the Care and Use of Laboratory Animals of Hokkaido
University Graduate School of Medicine and conformed to the Guide for
the Care and Use of Laboratory Animals published by the US National
Institutes of Health.
2.1. TAC operation
As previously described by Rockman et al. [8], TAC was created in
male C57BL/6J mice (7 to 10 weeks old and 19 to 26 g body weighte under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Photographs of TAC operation. (A) Mice were subjected to TAC operation using the gauge. (B) Three gauges used with TAC operation: top; a 0.400 mm gauge needle, middle; a
0.385 mm pin gauge, bottom; a 0.375 mm pin gauge.
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transverse aorta. All procedures were performed by a single operator.
Brieﬂy, mice were anesthetized with a combination anesthetic,
called MMB, via intraperitoneal administration. We mixed 3 drugs;
0.3 mg/kg of medetomidine (Dorbene® Kyoritsuseiyaku Co., Ltd.,
Tokyo, Japan), 4.0 mg/kg of midazolam (Dormicum®, Astellas Pharma
Inc., Tokyo, Japan), and 5.0 mg/kg of butorphanol (Vetorphale®, Meiji
Seika Kaisha, Ltd., Tokyo, Japan) [9]. Mice were placed on the pad in
the dorsal position, and then the limbs were ﬁxed with surgical tapes.
Mice were intubated, the tube connected to experimental rodent venti-
lators (Shinano Co., Ltd., Tokyo, Japan) under the condition of 120
breaths per minutes and 0.3 ml tidal volume.
The skin from the neckline to the diaphragm was disinfected with
70% alcohol. After thoracic incisionwith the scissor, the second intercos-
tal space through a small incision with the forceps, the thymus being
divided into two pieces, the transverse aorta was exposed with four
rib spreaders. A 7–0 nylon (Akiyama Co., Ltd., Yamanashi, Japan) suture
ligature was “very tight without deformation of the nylon” tied around
the transverse aortawith a thinmetal rod to produce a constriction after
removal of the rod (Fig. 1A). Three kinds of thinmetal rodswere used in
the present study; the 27 gauge medical needle with a 0.400 mm OD
(TERUMO Co., Ltd., Japan), the pin gauges for industrial use with a
0.385 mm OD and a 0.375 mm OD (EISEN Co., Ltd., Shiga, Japan).
The picture of these 3 gauges used in the present study was shown in
Fig. 1B. Their ODs were conﬁrmed and analyzed with ImageJ software
(data not shown). The intercostal muscle, the greater pectoral muscle
and the skin were closed by a 4–0 suture, respectively. After spontane-
ous breathing appeared, micewere extubated andmoved into a cage on
a padmaintained at 37 °C up to nextmorning. Sham operationwas also
performed.
2.2. Experiment 1
Micewere randomly divided into sham(n=21) and 3 different TAC
groups operated by metal rods with a 0.400 mm OD (n = 11), aFig. 2. Survival curves in TAC operation. (A)Micewere subjected to TAC operation with three ki
29; 0.375 mm, n = 22. (B) Mice were subjected to TAC operation with the 0.385 mm pin gaug0.385 mm OD (n = 29), and a 0.375 mm OD (n = 22). These mice
were observed for 4 weeks.
2.3. Survival
The survival analysis was performed in all groups of mice. During
four weeks after operation, the cages were inspected daily for dead an-
imals. All dead mice were examined for the presence of TAC.
2.4. Echocardiographic measurements
At four weeks after operation, echocardiographic measurements
were performed in surviving mice under light anesthesia with
tribromoethanol/amylene hydrate (avertin; 2.5% wt/vol, 8 μl/g ip), as
described previously [10]. A two-dimensional parasternal short-axis
views were obtained at the levels of the papillary muscles. In general,
the best views obtained with the transducer lightly applied to the mid
upper left anterior chest wall. The transducer was then gently moved
cephalad or caudad and angulated until desirable images were obtain-
ed. After it had been ensured that the imaging was on axis, two-
dimensional targeted M-mode tracings were recorded at a paper
speed of 50 mm/s.
2.5. Organ weights
After an addition of avertin, mice were euthanized by cervical dislo-
cation under deep anesthesiawith avertin (2.5%wt/vol, total 10 μl/g ip).
Hearts and lungs were then excised and weighed.
2.6. Experiment 2
Another set of mice was divided into control (n = 11), and TAC
group operated by metal rods with a 0.385 mm OD and observed for
oneweek (n=15). Thesemicewere comparedwith TACmice operatednds of gauges and followed for 4 weeks. Sham, n= 21; 0.400mm, n= 11; 0.385mm, n=
e and followed for 5 months. n = 20.
Table 2
LV Function and Structure following TAC with the 0.385 mm pin gauge.
Control 1 Week 4 Weeks
N 11 9 15
BW(g) 21.4 ± 0.3 20.6 ± 0.5 24.4 ± 0.3⁎,†
Organ weights
HW/BW(mg/g) 4.7 ± 0.0 7.3 ± 0.2⁎ 9.7 ± 0.5⁎,†
LVW/BW(mg/g) 3.3 ± 0.1 5.4 ± 0.2⁎ 6.7 ± 0.3⁎,†
Lung/BW(mg/g) 6.4 ± 0.1 9.5 ± 1.1 14.1 ± 1.5⁎,†
⟨Echocardiographic data⟩
N 8 7 14
HR(bpm) 541 ± 11 557 ± 14 520 ± 19
LV EDD(mm) 3.2 ± 0.1 2.7 ± 0.1 3.8 ± 0.2⁎,†
LV ESD(mm) 1.6 ± 0.1 1.5 ± 0.2 2.6 ± 0.2⁎,†
%FS 51 ± 3 46 ± 5 32 ± 3⁎,†
Anterior wall thickness(mm) 0.8 ± 0.0 1.2 ± 0.1⁎ 1.0 ± 0.1⁎
Posterior wall thickness(mm) 0.8 ± 0.0 1.2 ± 0.1⁎ 1.0 ± 0.1⁎
⟨Hemodynamic data⟩
N 8 7 7
HR(bpm) 543 ± 20 521 ± 15 536 ± 23
Ao SBP(mmHg) 130 ± 3 179 ± 3⁎ 243 ± 6⁎,†
Ao DBP(mmHg) 91 ± 4 77 ± 3⁎ 85 ± 4
LV EDP(mmHg) 1.8 ± 0.5 7.0 ± 2.4 8.2 ± 1.6⁎
Data are shown asmean± SE. N, number; BW, bodyweight; HW, heart weight; LVW, left
ventricle weight; HR, heart rate; EDD, end-diastolic diameter; ESD, end-systolic diameter;
%FS, percent fractional shortening; Ao, aorta; SBP, systolic blood pressure; DBP, diastolic
blood pressure; EDD, end-diastolic pressure.
⁎ P b 0.05 vs. Control.
† P b 0.05 vs. 1 Week.
Table 1
LV function and structure after four weeks after TAC.
Sham 0.400 0.385 0.375
N 21 9 15 9
Organ weights
BW (g) 26.0 ± 0.3 24.8 ± 0.4 24.4 ± 0.3⁎ 23.7 ± 0.7⁎
HW/BW (mg/g) 4.4 ± 0.0 6.6 ± 0.3⁎ 9.7 ± 0.5⁎,† 10.2 ± 0.8⁎,†
LVW/BW (mg/g) 3.1 ± 0.0 4.9 ± 0.2⁎ 6.7 ± 0.3⁎,† 7.1 ± 0.5⁎,†
Lung/BW (mg/g) 5.8 ± 0.1 6.4 ± 0.4 14.1 ± 1.5⁎,† 16.1 ± 2.2⁎,†
⟨Echocardiographic data⟩
N 21 9 14 9
HR (bpm) 532 ± 10 505 ± 17 520 ± 19 496 ± 16
LV EDD (mm) 3.2 ± 0.1 3.2 ± 0.2 3.8 ± 0.2⁎ 3.8 ± 0.2⁎
LV ESD (mm) 1.7 ± 0.1 2.0 ± 0.2 2.6 ± 0.2⁎ 2.6 ± 0.2⁎
%FS 47 ± 2 38 ± 5 32 ± 3⁎ 32 ± 3⁎
Anterior wall thickness
(mm)
0.8 ± 0.0 1.2 ± 0.1⁎ 1.0 ± 0.1⁎ 1.2 ± 0.1⁎
Posterior wall thickness
(mm)
0.8 ± 0.0 1.2 ± 0.1⁎ 1.0 ± 0.1⁎ 1.2 ± 0.1⁎
Data are shown asmean± SE. N, number; BW, bodyweight; HW, heart weight; LVW, left
ventricle weight; HR, heart rate; EDD, end-diastolic diameter; ESD, end-systolic diameter;
%FS, percent fractional shortening.
⁎ P b 0.05 vs. Sham.
† P b 0.05 vs. 0.400 mm.
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29) in Experiment 1.
2.7. Hemodynamic measurements, and organ histology
After echocardiographic study, a 1.4-Fr micromanometer-tipped
catheter (Millar Instruments, Houston, TX) was inserted into the right
carotid artery, advanced to aorta and into the LV to measure pressures
in the ascending aorta and the LV.
For histological analysis, tissue was ﬁxed in 10% formaldehyde, cut
into three transverse sections; apex, middle ring, and base, then stained
with hematoxylin-eosin and Masson's trichrome. Myocyte cross-
sectional area and collagen volume fraction were determined as de-
scribed previously [10].
2.8. Statistical analysis
Data are expressed asmean±SEM. Survival analysis was performed
by the Kaplan–Meiermethod, and between-group differences in surviv-
al were tested by the log-rank test. A between-group comparison of
means was performed by one-way ANOVA, followed by t-test. The
Tukey correction was applied for multiple comparisons of means.
P b 0.05 was considered statistically signiﬁcant.
3. Results
3.1. Experiment 1
During the perisurgical period from the beginning of administrating
anesthetic to 24 h after TAC, no mice died without accidental events
such as bleeding around aortic arch or pneumothorax (usually less
than 5%). Up to seven days after TAC operation, about 20–50% of TAC
mice died of acute HF due to pressure overload by TAC, which was con-
ﬁrmed by pulmonary edema. From seven days after TAC to one month,
TACmice seldomdied. Survival curve analysis showed the lower surviv-
al rate as the thinner metal rods were used for TAC operation. Survival
rate of the 0.400 mm, the 0.385 mm, and the 0.375 mm groups was
82%, 59%, and 48%, respectively (Fig. 2A). All TAC mice with 0.385 mm
gauge died within ﬁve months after TAC operation, suggesting that all
of mice by TAC with 0.385 mm gauge, even if having varying degrees,
suffered from HF. (Fig. 2B).
Organweight and echocardiographic data were shown in Table 1. At
four weeks after TAC, while heart weight/BW, LV weight/BW and wall
thickness were higher in the 0.400 mm group than sham group, lung
weight/BW, LV dimension, and fractional shortening were similar, sug-
gesting the 0.400 mm group were in the state of hypertrophy without
LV dysfunction and HF. Both in the 0.385 mm group and the
0.375 mm group, heart weight/BW, LV weight/BW, lung weight/BW,
LV end-diastolic diameter (LVEDD) and LV end-systolic diameter
(LVESD) were signiﬁcantly increased and fractional shortening was de-
creased compared to sham group. There were no signiﬁcant differences
in all parameters in both groups. These results suggested that both
groups of mice were in the state of HF with LV systolic dysfunction.
3.2. Experiment 2
Given the survival rate and severity of HF, TAC operation with a
0.385mmODwas suitable for the experimental model of the transition
from compensated cardiac hypertrophy to HF. We next examined the
time course in this group. Heart weight/BW and LV weight/BW were
signiﬁcantly increased in TAC 1 week group compared with control
group and further increased in TAC 4 weeks group (Table 2). Lung
weight/BWwasnot altered in TAC 1week group comparedwith control
group, and was signiﬁcantly increased in TAC 4 weeks group (Table 2).
In parallelwith these results, echocardiography showed LVhypertrophy
without LV dilation and LV systolic dysfunction in TAC 1 week group(Table 2, Fig. 3A and B). On the contrary, it showed LV dilation and
LV systolic dysfunction in TAC 4 weeks group (Table 2, Fig. 3A and
B). Myocyte cross-sectional area and collagen volume tended to be
increased in TAC 1 week group compared with sham group and sig-
niﬁcantly increased in TAC 4 weeks group (Fig. 3C–F). Systolic
blood pressure in proximal of aortic constriction was signiﬁcantly in-
creased in TAC 1 week compared with sham group, and further in-
creased in TAC 4 weeks group (Table 2). LV end-diastolic pressures
were signiﬁcantly increased in TAC 4 weeks group to sham group
(Table 2).
We measured echocardiographic data before, 1 week and 4 weeks
after TAC in each mouse to conﬁrm that the mice operated with
0.385 mm gauge caused the transition from compensated LV hypertro-
phy to LV dysfunction and HF. They showed LV hypertrophy at 1 week
and LV dysfunction at 4 weeks (data not shown).
Fig. 3. Representative echocardiographic and histological images of control, and 1 and 4weeks after TAC operationwith the 0.385mmpin gauge. (A) Representative echocardiograph and
histological images from the various groups. (B) Representative histological images from the various groups. Scale Bar, 500 μm. (C) Hematoxylin and eosin (HE) stains from the various
groups. (D) Masson trichrome (MT) stains from the various groups. (E) Summary data for cross sectional area. n = 3 for each. Scale Bar, 100 μm. (F) Summary data for collagen volume.
n = 3 for each. Scale Bar, 100 μm. ⁎P b 0.05 vs. Control, †P b 0.05 vs. 1 Week, Ctrl, Control; 1 Week, 1 Week; 4 Weeks, 4 Weeks.
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The main ﬁnding of present study was that the use of 0.385 mmOD
gauge was suitable for TAC operation from the point of view of survival
and severity of HF. The use of thicker gauge (0.400mmOD) led to LVhy-
pertrophy and showed higher survival rate than 0.385 mm OD gauge,
but did not lead to HF. The use of thinner gauge (0.375mmOD) induced
HF, but showed low survival rate. Furthermore, the use of 0.385mmOD
gauge caused the transition from LV hypertrophy in early phase to LV
dysfunction and HF in late phase.
TACmodel has been commonly used, but has been thought to have a
diversity of the severity of LV remodeling or HF. Some factors affecting
the diversity have been known. Most important factor is the pressure
gradient via trans-constriction with TAC, which is determined by aortic
diameter, needle size, and tightness of ligature. To control the tightness
of ligature is the most difﬁcult task and is easily inﬂuenced by artiﬁcial
factors during procedure of TAC operation. Therefore, we uniformed it
by very tightly ligating without deformation of the nylon suture to
avoid artiﬁcial factors. To minimize the variation of aortic diameter at
operation, we used mice with a narrow range of BW. We further strati-
ﬁed mice by BW. Mice operated with 0.385 mmwere divided into two
groups; 19–22.5 g (lower BW group) and 22.5–26 g (higher BW
group). The survival rates and the severity of LV remodeling or HF
of lower BW group and higher BW group in 0.385 mm mice were
similar (data not shown). Another problem is an increase in aortic
diameter with growth after TAC operation. Aortic diameter may be
affected by growth during long-term experiment. Therefore, we per-
formed relatively short-term experiment, and created mice model of
HF by TAC for four weeks. Our model had more severe phenotypethan other report, but no mice died within 24 h after TAC operation
and mortality rate was comparable during 4 weeks [11]. These re-
sults would be due to our technical advantage. We could evaluate
the effects of needle size by regulating these factors affecting the
diversity of TAC operation.
There are some limitations that should be acknowledged in the pres-
ent study. First, we used inbred strain mice, which is suggested to have
inherited individual variation. Indeed, it has been reported that parent
of origin may affect the response to cardiac stress after TAC [2]. We
did not control the parent of origin, which, however, did not have any
contribution to our results. Second, we did not measure the pressure
gradient via trans-constriction with TAC. Therefore, we could not
prove that the pressure gradient was ﬁnely regulated by our procedure.
However, our results of cardiac phenotype and mortality rate after TAC
showed that it was the case.
This is the ﬁrst report showing how to steadily create hypertrophy
and HF by TAC. This method is important for decreasing the number
of mice used for experiments, and also contributes obviously to animal
protection.
5. Conclusions
TAC with the diameter of 0.385 mm can effectively induce the tran-
sition from LV hypertrophy to HF in mice with relatively preserved
survival.
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